Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 25, 2014

View Archived Issues

FDA grants orphan drug status to cannabidiol for pediatric schizophrenia

Proteo discloses results from phase II study of Elafin in myocardial reperfusion injury

Small-molecule MIF inhibitors tested in the collagen-induced arthritis mouse model

Novogen identifies lead ATM drug candidate

First clinical data showed that KTN-3379 is well tolerated in advanced solid tumors

Early results for E-7438 show response in patients with lymphoma and advanced solid tumors

In vivo data for novel P. falciparum multi-antigen, multistage adenovirus vectored vaccine

Max-Planck-Gesellschaft and BTI divulge natural PPAR modulators

Sanofi develops novel CD38 inhibitors

Principia Biopharma reports discovery of FGFR inhibitors

EMA issues new recommendations for the use of Corlentor/Procoralan

CHMP recommends granting marketing authorization for Shionogi's Senshio

Merck & Co. and NewLink Genetics collaborate on investigational Ebola vaccine

EMA committee recommends approval of Travatan for use in pediatric patients

Amgen terminates all Amgen-sponsored studies of rilotumumab in advanced gastric cancer

Primary endpoint met in phase II study of TriMix-DC-MEL melanoma vaccine

Janssen files NDA for Yondelis for advanced soft tissue sarcoma

Merck & Co. files for Japanese approval of omarigliptin for type 2 diabetes

NPS Pharmaceuticals' teduglutide receives orphan drug status in Japan for short bowel syndrome

Synthetic Biologics cleared to begin phase I trials of SYN-004

FDA awards orphan drug designation to CAT-1004 for Duchenne muscular dystrophy

FDA grants QIDP designations to Bayer's Amikacin Inhale and ciprofloxacin DPI

Bristol-Myers Squibb and Five Prime to evaluate combination of Opdivo and FPA-008

Vorapaxar receives positive opinion from EMA

Juno Therapeutics' JCAR-015 designated a Breakthrough Therapy by FDA

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...